非小細胞肺がん:グローバル医薬品市場(~2022)...市場調査レポートについてご紹介

【英文タイトル】PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 9
1.1 List of Tables 16
1.2 List of Figures 22
2 Introduction 24
2.1 Catalyst 24
2.2 Related Reports 25
2.3 Upcoming Related Reports 25
3 Disease Overview 26
3.1 Etiology and Pathophysiology 26
3.1.1 Etiology 26
3.1.2 Pathophysiology and Histology 26
3.1.3 NSCLC Biomarkers 27
3.1.4 Quality of Life 28
3.2 Symptoms 29
4 Epidemiology 31
4.1 Risk Factors and Comorbidities 32
4.1.1 Smokers are more likely to have lung cancer than non-smokers 33
4.1.2 Long-term exposure to radon increases the risk of lung cancer 35
4.1.3 Family history of any cancer increases lung cancer risk 35
4.1.4 TB increases the risk of lung cancer and increases mortality risk 35
4.1.5 COPD is a comorbidity that reduces lung cancer survival 36
4.1.6 Lung cancer screening programs may not be beneficial 36
4.1.7 Stage at diagnosis significantly impacts the survival of lung cancer cases 37
4.2 Global Trends 38
4.2.1 US 41
4.2.2 France 46
4.2.3 Germany 47
4.2.4 Italy 49
4.2.5 Spain 51
4.2.6 UK 53
4.2.7 Japan 54
4.2.8 China 56
4.2.9 India 58
4.3 Forecast Methodology 60
4.3.1 Sources Used 62
4.3.2 Sources Not Used 67
4.3.3 Forecast Assumptions and Methods 67
4.4 Epidemiology Forecast (2012-2022) 70
4.4.1 Incident/Prevalent Cases of NSCLC 70
4.4.2 Age-Specific Incident Cases of NSCLC 72
4.4.3 Sex-Specific Incident Cases of NSCLC 73
4.4.4 Age-Standardized Incidence Rates of NSCLC 75
4.4.5 Segmentation of NSCLC Incident Cases 76
4.5 Discussion 84
4.5.1 Limitations of the Analysis 85
4.5.2 Strengths of the Analysis 86
5 Disease Management 87
5.1 Treatment Overview 87
5.1.1 Diagnosis 88
5.1.2 Clinical Staging 89
5.1.3 Screening and Early Detection 91
5.1.4 Localized Procedures and Therapies 92
5.1.5 Systemic Chemotherapy 93
5.1.6 Targeted Therapy 93
5.2 US 96
5.2.1 Diagnosis 96
5.2.2 Clinical Practice 96
5.3 France 98
5.3.1 Diagnosis 98
5.3.2 Clinical Practice 99
5.4 Germany 100
5.4.1 Diagnosis 100
5.4.2 Clinical Practice 101
5.5 Italy 103
5.5.1 Diagnosis 103
5.5.2 Clinical Practice 104
5.6 Spain 105
5.6.1 Diagnosis 105
5.6.2 Clinical Practice 105
5.7 UK 106
5.7.1 Diagnosis 106
5.7.2 Clinical Practice 107
5.8 Japan 108
5.8.1 Diagnosis 108
5.8.2 Clinical Practice 109
5.9 China 110
5.9.1 Diagnosis 110
5.9.2 Clinical Practice 111
5.10 India 112
5.10.1 Diagnosis 112
5.10.2 Clinical Practice 112
6 Competitive Assessment 115
6.1 Overview 115
6.2 Strategic Competitor Assessment 116
6.3 Product Profiles – Major Brands, Chemotherapies 118
6.3.1 Alimta (pemetrexed disodium) 118
6.3.2 Abraxane (nab-paclitaxel) 123
6.4 Product Profiles – Major Brands, Targeted Therapies 127
6.4.1 Avastin (bevacizumab) 127
6.4.2 Gilotrif (afatinib) 132
6.4.3 Iressa (gefitinib) 138
6.4.4 Tarceva (erlotinib hydrochloride) 143
6.4.5 Xalkori (crizotinib) 149
7 Opportunity and Unmet Need 156
7.1 Overview 156
7.2 Improved Overall Survival and Less Toxicity 157
7.3 Treatments for Patients with Acquired TKI Resistance 158
7.4 Better Treatment Options for Squamous Patients 158
7.5 Preventing Relapse or Recurrence 159
7.6 More Efficacious Second-Line Therapies 159
7.7 Increased Availability of Mutation Testing 160
7.8 More Cost-Effective Therapies 160
7.9 Unmet Needs Gap Analysis 161
8 Pipeline Assessment 165
8.1 Overview 165
8.2 Clinical Trial Mapping 165
8.2.1 Clinical Trials by Country 165
8.3 Clinical Trials by Phase and Trial Status 167
8.4 Promising Drugs in Clinical Development 168
8.4.1 Onartuzumab (MetMab) 172
8.4.2 Necitumumab (IMC-11F8) 177
8.4.3 Ramucirumab (IMC-1121B) 183
8.4.4 Custirsen (OGX-011) 188
8.4.5 Ganetespib (STA-9090) 194
8.4.6 Nintedanib (BIBF1120) 201
8.4.7 Dacomitinib (PF-00299804) 206
8.4.8 LDK378 (ceritinib) 211
8.4.9 Yervoy (ipilimumab) 217
8.4.10 Nivolumab (BMS936558) 222
8.4.11 MPDL3280A (RG7446) 230
8.4.12 GSK1572932A (MAGE-A3 Cancer Immunotherapy) 233
8.4.13 Halaven (eribulin mesylate) 237
9 Current and Future Players 243
9.1 Overview 243
9.2 Trends in Corporate Strategy 245
9.3 Company Profiles 246
9.3.1 Roche/Genentech 246
9.3.2 Pfizer 249
9.3.3 Bristol-Myers Squibb 251
9.3.4 Eli Lilly 254
9.3.5 Boehringer Ingelheim 257
9.3.6 Novartis 259
10 Market Outlook 261
10.1 Global Markets 261
10.1.1 Forecast 261
10.1.2 Drivers and Barriers – Global Issues 265
10.2 United States 269
10.2.1 Forecast 269
10.2.2 Key Events 273
10.2.3 Drivers and Barriers 274
10.3 France 277
10.3.1 Forecast 277
10.3.2 Key Events 281
10.3.3 Drivers and Barriers 282
10.4 Germany 284
10.4.1 Forecast 284
10.4.2 Key Events 288
10.4.3 Drivers and Barriers 289
10.5 Italy 291
10.5.1 Forecast 291
10.5.2 Key Events 295
10.5.3 Drivers and Barriers 295
10.6 Spain 297
10.6.1 Forecast 297
10.6.2 Key Events 300
10.6.3 Drivers and Barriers 301
10.7 United Kingdom 302
10.7.1 Forecast 302
10.7.2 Key Events 306
10.7.3 Drivers and Barriers 307
10.8 Japan 309
10.8.1 Forecast 309
10.8.2 Key Events 313
10.8.3 Drivers and Barriers 313
10.9 China 316
10.9.1 Forecast 316
10.9.2 Key Events 320
10.9.3 Drivers and Barriers 320
10.10 India 323
10.10.1 Forecast 323
10.10.2 Key Events 327
10.10.3 Drivers and Barriers 327
11 Appendix 329
11.1 Bibliography 329
11.2 Abbreviations 360
11.3 Methodology 365
11.4 Forecasting Methodology 365
11.4.1 Number of NSCLC Patients Currently Seeking Treatment 365
11.4.2 Percent Drug-Treated Patients 366
11.4.3 Drugs Included in Each Therapeutic Class 366
11.4.4 Launch and Patent Expiry Dates 367
11.4.5 General Pricing Assumptions 368
11.4.6 Individual Drug Assumptions 371
11.4.7 Generic Erosion 381
11.4.8 Pricing of Pipeline Agents 381
11.5 Physicians and Specialists Included in This Study 383
11.6 Survey of Prescribing Physicians 385
11.7 About the Authors 386
11.7.1 Authors 386
11.7.2 Epidemiologists 387
11.7.3 Global Head of Healthcare 388
11.8 About GlobalData 389
11.9 Disclaimer 389


【レポート販売概要】

■ タイトル:非小細胞肺がん:グローバル医薬品市場(~2022)
■ 英文:PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update
■ 発行日:2014年4月30日
■ 調査会社:GlobalData
■ 商品コード:GDHC002EPIDR
■ 調査対象地域:グローバル
  • PA Resources AB:石油・ガスの開発・生産動向及びコスト分析– Q1, 2013
    PA Resources AB Oil & Gas Exploration and Production Operations and Cost Analysis – Q1, 2013 Summary PA Resources AB Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key ope …
  • グローバル電力産業におけるM&A及び投資動向:2014年1月
    Power Monthly Deal Analysis - January 2014: M&A and Investment Trends Summary GlobalData's “Power Monthly Deal Analysis - January 2014: M&A and Investment Trends” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the power industry. The report provides detailed information on M&As, equity/debt offerings, private equity, venture financ …
  • 世界のヒューマンマシンインターフェース(HMI)市場動向(2014~2018)
    TechNavio's analysts forecast the Global Human Machine Interface (HMI) market to grow at a CAGR of 9.98 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growth in industrial automation. The Global HMI market has also been witnessing the development of next-generation systems. However, the continuous decline in product prices could pose a challenge …
  • 地上支援装置(GSE)の世界市場:乗客、貨物、航空機
    The global ground support equipment (GSE) market has been estimated to be worth USD 12.22 Billion in 2016, and is projected to reach USD 19.44 Billion by 2021, at a CAGR of 9.72%. Some of the key drivers for the growth of the ground support equipment market include rise in air traffic and increasing focus by airports towards enhancing their operational efficiency. The outsourcing of maintenance, r …
  • モバイル暗号化の世界市場予測(~2022年):ディスク暗号化、ファイル/フォルダ暗号化、通信暗号化、クラウド暗号化
    “Need for stringent compliance and increasing concern for data security are driving the mobile encryption market.”The mobile encryption market size is expected to grow from USD 761.4 million in 2017 to USD 2,917.9 million by 2022, at a Compound Annual Growth Rate (CAGR) of 30.8%. The market is driven by factors such as increased concerns for data security and privacy issues, the proliferation of s …
  • スペインの呼吸装置市場
    Spain Respiratory Devices Market Outlook to 2021 Summary GlobalData’s new report, "Spain Respiratory Devices Market Outlook to 2021", provides key market data on the Spain Respiratory Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Humidifiers, Oxygen Concentrators, Ventilators, Nebulizers, Pos …
  • ステアリング装置の世界市場:EPS(電動パワーステアリング)、EHPS、HPS(油圧パワーステアリング)
    The steering system market size is projected to grow at a promising CAGR of 6.18% during the forecast period, to reach USD35.99 Billion by 2020. The recent increase in demand for automobiles in the U.S. and Mexico has confirmed that the North American automotive industry has begun its recovery phase and according to industry experts, the market is projected to continue with a similar growth trend …
  • 航空機向けサイバーセキュリティの世界市場2016-2020
    About the Aviation Cyber Security Market The introduction of new technologies without robust cyber security measures presents a risk to the aviation industry. The risk is due to the cyber threats that are likely to increase during the forecast period. The aviation industry stakeholders such as cargo firms, airports, and airlines must recognize the risks to their networks and control systems from c …
  • Mobile Handsets and Applications September 2010
    The Mind Commerce Mobile Handsets and Application report focuses on recent news and events in the Mobile Handset market. The Newsletter brings you stories on the major players and devices in the Cellular Handset industry. We will monitor the trends in the Smartphone market; examine new technology trends and their impact on the marketplace. We study and comment on press announcements from Apple, An …
  • クレーンの世界市場:移動式クレーン、海上クレーン/港湾クレーン、定置式クレーン
    About Global Crane Market The global crane market forms an integral part of the global construction equipment market. Cranes can be broadly categorized as mobile cranes, marine and port cranes, and fixed cranes based on their load lifting capacity, lift height, and outreach. The global crane market is currently undergoing a radical change, fueled by the growth of emerging economies and exponential …
  • 除毛用製品の世界市場:除毛器、除毛クリーム、除毛ワックス
    About the Depilatory Products Market With more women entering the global workforce, the demand for and the affordability of depilatory products have increased. The rising numbers of salons and spas also increase product use. The following methods are commonly used for hair removal and there are many products to make the task easy. • Shaving • Creams • Waxing • Sugaring • Laser treatment • Electrol …
  • トルクコンバータの世界市場予測(~2025年):AT、DVT、DCT、クラッチプレート、ダンパー、インペラー、タービン、固定子、車両、ハイブリッド車、アフターマーケット、地域別分析
    The torque converter market, by value, is projected to grow at a CAGR of 5.78% from 2017 to 2025, to reach USD 9.88 Billion by 2025. The key factors driving the market growth include the increasing penetration of automatics in mid-segment vehicles and the increasing sale of premium segment vehicles. The rapid growth of the hybrid vehicle market is also expected to boost the demand for torque conve …
  • 粘着テープの世界市場2016-2020
    About Adhesive Tapes Adhesive tapes stick to substances when pressure is applied, without the need for solvent, heat, or any other activator. Adhesives are coated on these tapes, either on one side or both sides. Many variants like single-sided, double-sided, adhesive transfer or transfer adhesive, single-coated, double-coated, carton sealing, masking, electrical and electronics are available in t …
  • 世界のクロロメタン市場2015
    The Global Chloromethanes Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Chloromethanes industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Chloromethanes market analysis is provided for the international markets including development trends, compe …
  • 虚血性心筋症(Ischemic Cardiomyopathy):治療薬のグローバル治験動向(2014年下半期)
    Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2014" provides data on the Ischemic Cardiomyopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ischemic Cardiomyopathy. It includes an overview of the trial numbers …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。